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To identify genetic loci for autism-spectrum disorders, we have performed a two-stage genomewide scan in 38
Finnish families. The detailed clinical examination of all family members revealed infantile autism, but also Asperger
syndrome (AS) and developmental dysphasia, in the same set of families. The most significant evidence for linkage
was found on chromosome 3q25-27, with a maximum two-point LOD score of 4.31 (Zmax dom) for D3S3037, using
infantile autism and AS as an affection status. Six markers flanking over a 5-cM region on 3q gave Zmax dom 13,
and a maximum parametric multipoint LOD score (MLS) of 4.81 was obtained in the vicinity of D3S3715 and
D3S3037. Association, linkage disequilibrium, and haplotype analyses provided some evidence for shared ancestor
alleles on this chromosomal region among affected individuals, especially in the regional subisolate. Additional
potential susceptibility loci with two-point LOD scores 12 were observed on chromosomes 1q21-22 and 7q. The
region on 1q21-22 overlaps with the previously reported candidate region for infantile autism and schizophrenia,
whereas the region on chromosome 7q provided evidence for linkage 58 cM distally from the previously described
autism susceptibility locus (AUTS1).
Introduction
Infantile autism (MIM 209850) is characterized by ab-
normalities in reciprocal social interaction and commu-
nication, restricted and stereotyped patterns of interests
and activities, and the presence of developmental abnor-
malities by 3 years of age. Together with Asperger syn-
drome (AS), it belongs to the disease spectrumofpervasive
developmental disorders. Although family studies have
reported increased rates of language disorders in relatives
of autistic probands, the reasons for the observed asso-
ciation between autism and developmental language dis-
orders are currently unknown (Bailey et al. 1995, 1998;
Fombonne et al. 1997; Pickles et al. 2000). Comparative
studies of autism and developmental language disorders
have indicated that the distinction between the phenotype
traits is more pronounced in childhood and tends to ame-
liorate later on (Howlin et al. 2000; Mawhood et al.
2000). Consequently, recommendations have been made
for more broadly defined diagnostic criteria for autism
(Piven et al. 1997a; Folstein et al. 1998).
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Genetic susceptibility to autism is implicated by the
findings of increased concordance rates of 69%–98%
among MZ twins, compared with rates of 0%–30%
among DZ twins (Folstein and Rutter 1977; Steffenburg
et al. 1989; Bailey et al. 1995), and a 3%–5% recur-
rence risk for siblings (Smalley 1997). Eight genome
scans performed so far for the autism loci have provided
suggestive evidence for linkage to several chromosomal
regions (International Molecular Genetic Study of Au-
tism Consortium [IMGSAC] 1998; Collaborative Link-
age Study of Autism [CLSA] 1999; Philippe et al. 1999;
Risch et al. 1999; Buxbaum et al. 2001; IMGSAC
2001b; Liu et al. 2001; Shao et al. 2002b), reflecting
both genetic and clinical heterogeneity of this complex
trait. The most convincing linkage finding has been ob-
served on chromosome 7q. Being originally detected in
British sibpair families, the 7q linkage was later repli-
cated in multiple genome scans and in several popu-
lations (CLSA 1999; Philippe et al. 1999; Risch et al.
1999; IMGSAC 2001b; Buxbaum et al. 2001; Liu et al.
2001). Recently, this locus, designated “AUTS1,” was
studied in 153 IMGSAC families, resulting in a multi-
point LOD score (MLS) of 3.37 at D7S477 (IMGSAC
2001a). Another interesting region is 2q, a region for
which overlapping linkage results have been generated
in several genome scans (Philippe et al. 1999; Buxbaum
et al. 2001; IMGSAC 2001b; Shao et al. 2002b). By
analysis of a subset of autistic patients with delayed
phrase speech, increased support for linkage on chro-
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Table 1
Family Material in Stage I and Stage II
DIAGNOSTIC
CRITERION PHENOTYPES
NO. IN STAGE I NO. IN STAGE II
Families Affected Individuals Families Affected Individuals
1 Autism 12 33 19 54
2 Autism, AS 18 42 28 72
3 Autism, AS, dysphasia 19 47 38 87
mosome 2 was obtained (Buxbaum et al. 2001; Shao
et al. 2002a).
So far, genetic studies of autism-spectrum disorders
have mainly focused on infantile autism, with aminority
of families or family members representing other trait
phenotypes (Philippe et al. 1999; Risch et al. 1999; Liu
et al. 2001). Since, in our nationwide collection of mul-
tiplex families, approximately one-third of the probands
with infantile autism were found to have a first-degree
relative with AS or developmental dysphasia, we de-
cided to include these phenotype traits as affection
status in our linkage studies. The spectrum of clinical
phenotype in our family sample is consistent with the
previous findings implying that relatives of autistic pro-
bands have an increased risk for language-related cog-
nitive disorders or deficits in social functioning (Bolton
et al. 1994; Fombonne et al. 1997; Pickles et al. 2000).
The genome scan in multiplex Finnish families affected
by the broad phenotype provided evidence for a new
autism locus on 3q25-27.
Material and Methods
Family Material
The families with two or more members with the
broad phenotype were recruited through a nationwide
search of university and central hospitals of Finland and
through the Finnish Association for Autism and Asper-
ger Syndrome. Thorough clinical and medical exami-
nations were performed by an experienced child neu-
rologist or pediatrician, by use, as screening instruments,
of the Childhood Autism Rating Scale (CARS), the As-
perger Syndrome Screening Questionnaire (ASSQ), and
the Asperger’s Syndrome Diagnostic Interview (ASDI)
(Ehlers and Gillberg 1993). Diagnoses were assessed ac-
cording to the Diagnostic and Statistical Manual of
Mental Disorders (DSM-IV, 4th edition) or ICD10 cri-
teria (World Health Organization 1993). Further, any
available information from speech therapists and neu-
ropsychologists was considered in the diagnostic eval-
uation. We paid particular attention to the classification
of the patients with developmental dysphasia. Reassess-
ment of dysphasia was performed by one specialist (R.V.)
for all the studied family members. Most of the patients
with developmental dysphasia (11/15) had receptive lan-
guage disorder (F80.2 according to ICD10), which is
similar to the DSM-IV diagnosis for mixed receptive-
expressive language disorder. Of 15 patients, 2 had the
expressive type of dysphasia (F80.1, according to
ICD10) similar to the DSM-IV diagnosis for expressive
language disorder; however, one of them was diagnosed
as having F80.2 in early childhood, and the other was
diagnosed later in life, at the age of 10 years. Further,
one young male patient with an autistic sibling was first
diagnosed to have the expressive type of dysphasia
(F80.1) and was handled as such in the analyses. Later,
he fulfilled the criteria for autism. In one subject, who
was first considered to be dysphasic and was treated as
such in the statistical analyses, not all the necessary di-
agnostic criteria for dysphasia or autism-spectrum dis-
order were fulfilled. Problems in social interaction and
language skills were observed; however, the diagnosis
remained unspecified. Families with associative medical
conditions, such as fragile-X syndrome, chromosomal
aberrations, neurocutaneous syndromes, and profound
mental retardation, were excluded. A blood sample was
taken from all the available first-degree relatives of the
probands. All families are Finnish, except for one, in
which the father was of Turkish origin. To determine
whether the families had any common ancestors, we
performed genealogical analyses using population reg-
isters (Varilo et al. 1996). These study protocols were
approved by the ethical committees of the Hospital for
Children and Adolescents of Helsinki University Hos-
pital and National Public Health Institute, Helsinki. In-
formed consent for genetic studies was obtained from
the subjects or their parents.
Genotyping
The initial genomewide scan (stage I) was performed
in 19 multiplex families with a total of 47 affected in-
dividuals (33 with infantile autism, 9 with AS, and 5
with developmental dysphasia), by use of 369 micro-
satellite markers from Weber screening set 6.0 (Sheffield
et al. 1995) (table 1 and fig. 1). In stage II, 19 additional
families with a total of 40 affected individuals (21 with
infantile autism, 9 with AS, and 10 with developmental
dysphasia) were included in the studies and were ge-
notyped using markers on nine promising chromosomal
regions. Of these 38 families, 17 had participated in the
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Figure 1 Pedigree structure for 19 families in the initial genomewide screen (stage I). Families 1 and 3 are linked genealogically and were
treated as one family. Blackened symbols denote infantile autism, symbols with diagonal lines denote AS, and symbols with vertical lines denote
developmental dysphasia.
analysis of the previously published susceptibility loci
for autism (Auranen et al. 2000). All the parents were
genotyped, except in three families for which one parent
was not available and one family for which both parents
were unavailable.
DNA was extracted from EDTA-treated blood ac-
cording to standard procedures (Blin and Stafford 1976).
PCR reactions were performed in 15-ml reaction vol-
umes containing 20 ng of genomic DNA, 6 pmol of both
primers, 0.2mM of dNTP, 1.5 mM MgCl2, 10 mM
TrisHCl, 50 mM KCl, 0.1% Triton X100, and 0.23 U
Dynazyme (Finnzymes Oy). The reactions were per-
formed using an MJ Research thermocycler and a hots-
tart procedure with Dynazyme that was added only after
the first denaturation step of 5 min at 95C. The DNA
amplification was carried out in 35 cycles as follows: 30
s at temperature specific for each primer (49–62C), 30
s at 72C and 30 s at 95C. An elongation step of 5 min
at 72C terminated the reaction after the last annealing.
Electrophoretic allele separation was performed using
an ABI automated DNA sequencer (Applera), and ge-
notypes were assigned using the Genotype 2.0 software
(Applera). Markers that failed to amplify reliably were
replaced by markers from the Ge´ne´thon marker map.
The fine-mapping markers were selected from the
Marshfield and the Genetic Location Database maps.
780 Am. J. Hum. Genet. 71:777–790, 2002
The genotypes were assigned by two independent indi-
viduals. For each marker, the allele frequencies were cal-
culated using the pedigree data itself. For genotype-error
elimination, the PEDCHECK, MENDEL, and SIM-
WALK2 programs were utilized (Lange et al. 1988; Sobel
and Lange 1996; O’ Connell and Weeks 1998). Hap-
lotypes were constructed using the GENEHUNTERpro-
gram (Kruglyak et al. 1996).
Statistical Analysis
In all analyses, individuals were designated as either
affected or unknown. All available samples of first-de-
gree relatives of the probands were genotyped. For sta-
tistical analyses, the families were classified into three
nested diagnostic categories defined by diagnostic cri-
terion 1, families with infantile autism only (19 families
); diagnostic criterion 2, families with infantile autism
and AS (28 families); and diagnostic criterion 3, families
with all three phenotypes (38 families). The maximum
two-point LOD scores (Zmax) under homogeneity were
calculated using the MLINK program of the LINKAGE
package (Lathrop and Lalouel 1984; Lathrop et al.
1986), and tests of heterogeneity and calculations of the
proportion of families showing linkage (a) were per-
formed using the HOMOG program (Ott 1986). Af-
fecteds-only analysis was performed under both auto-
somal dominant and autosomal recessive modes of
inheritance allowing no phenocopies, and the disease-
allele frequency was set at 104. Sib-pair analysis was
performed using the SIBPAIR program (Kuokkanen et
al. 1996). Nonparametric maximum multipoint LOD
scores (MLS) were calculated using the MAPMAKER/
SIBS and GENEHUNTER programs on autosomal and
X-chromosomal markers respectively (Kruglyak and
Lander 1995; Kruglyak et al. 1996). This analysis was
restricted to the information of the sib-pair families, and
the extended families were excluded from the analyses.
Consequently, 17 of 19 families fulfilling diagnostic cri-
terion 1, 25 of 28 families fulfilling diagnostic criterion
2, and 35 of 38 families fulfilling diagnostic criterion 3
were analyzed. In stage II, we used the information of
sib-pair families in parametric multipoint calculations
and in the construction of shared haplotypes. Parametric
MLSs were calculated utilizing the SIMWALK 2.81 pro-
gram (Sobel and Lange 1996). Association analysis was
performed by calculating the P values for the transmis-
sion/disequilibrium test (TDT) using Mendel 4.0 (Lange
et al. 2001), and likelihood-based haplotype relative risk
using the ANALYZE package (Terwilliger 1998). Gam-
ete-competition analysis (Sinsheimer et al. 2000), as im-
plemented in MENDEL 4.0 (Lange et al. 2001), was
used to estimate the degree of apparent bias in trans-
mission of alleles of the markers on chromosomes 1, 7,
and 3q to the affected offspring. Linkage disequilibrium
(LD) between the markers was calculated using the
GenePop 3.3 program. The extent of nonrandom allelic
association between pairs of loci was monitored in the
transmitted and nontransmitted alleles from the parents.
Differences in the allele and genotype frequency distri-
butions in the transmitted and nontransmitted alleles
from the parents were evaluated by an exact test for
population differentiation. These tests calculate the tail
probability (P value) for Fisher’s exact test. Additionally,
two-point LD analyses were performed using the DIS-
LAMB program (Terwilliger 1995).
Results
Genealogical Studies
We studied the church parish records (birth registers)
and the registers in the National Archives of Finland in
order to identify putative common ancestors for all 39
study families (Varilo et al. 1996). We were able to con-
struct two extended pedigrees merging five core families
with common ancestors in the 18th century. Two fam-
ilies with five affected individuals could be linked (Fam
1 and 3 in figs. 1 and 4), as well as three families with
one affected individual (pedigree not shown), all origi-
nating from central Finland. The genealogical infor-
mation was used in the two-point linkage analyses as
well as in TDT and HRR analyses. In 20 (51%) of 39
families studied, at least one grandparent originated
from central Finland, suggesting some clustering of the
clinical phenotype in this regional subisolate.
Primary Genome Scan (Stage I)
Diagnostic criterion 1.—Among 19 families included
in the initial genome scan, a total of 12 had two or more
sibs diagnosed as having infantile autism (table 1). In
linkage analyses of these families, nine chromosomal
regions showed a Zmax rec 11.0 (table 2 and fig. 2a). These
regions on chromosomes 1, 3p, 3q, 9, 12, 14, 17, 18,
and 21, as well as the AUTS1 locus on chromosome 7q,
were selected for fine mapping (stage II) with 19 addi-
tional families with autism, AS, and dysphasia. The most
encouraging findings in stage I were obtained on chro-
mosome 3q, on which several markers flanking a 15-
cM interval showed Zmax dom 11.0 (table 2).
Diagnostic criteria 2 and 3.—When the affection
status of the siblings was broadened to include not only
infantile autism but also AS (diagnostic criterion 2) and
dysphasia (diagnostic criterion 3), the number of families
with two or more affected individuals increased from 12
to 18 and 19, respectively. The markers showing some
evidence for linkage (Zmax 11) in both diagnostic crite-
rion 2 and 3 families were on chromosomes 1, 3p, 3q,
6, 19, and X (figs. 2b and 2c). On chromosome 1,
( ; ) and Zmax dom pZ p 1.76 vp 0.00 ap 1.0max dom
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Table 2
Markers Showing Zmax rec 11.0 for Patients with
Autism in Stage I
Marker
Distance
(cM) Zmax rec v a
D1S1675 149.20 1.0 0 1.0
D3S3038 44.81 1.60 .14 .64
D3S4009 137.0 1.60 0 .59
D3S3554 152.62 1.64 .10 1.0
D3S3053 181.87 1.10 .04 .65
D3S2427 188.29 1.45 .16 1.0
D3S2418 215.84 1.40 .12 1.0
D9S158 161.71 1.62 0 .64
D12S2078 149.60 1.02 .14 1.0
D14S297 31.75 1.53 .10 1.0
D17S784 116.86 1.43 .04 .51
D18S59 .00 1.22 0 .40
D21S1440 36.1 1.29 0 .44
NOTE.—LOD score values. The v values and
the proportion of families showing linkage (a)
are allowed to vary between 0 and 0.5 and be-
tween 0 and 1.0, respectively.
1.42 ( ; ) were observed at D1S1675 invp 0.1 ap 1.0
individuals affected under criterion 2 and criterion 3,
respectively. On chromosome 3p, the highest LOD
scores were found at D3S3608 (Zmax rec p 2.84; vp
; ) and Zmax rec p 3.13 ( ;0.06 ap 0.74 vp 0.08 ap
), on chromosome 3q at D3S3554 with Zmax rec p0.80
1.79 ( ; ) and Zmax rec p 2.40 (vp 0.04 ap 0.64 vp
; ), on chromosome 6 at D6S1021 with0.06 ap 0.73
Zmax recp 1.58 ( ; ) and Zmax recp 1.72vp 0.02 ap 0.48
( ; ), and on chromosome 19 atvp 0.04 ap 0.53
D19S433 with Zmax rec p 1.92 ( ; ) andvp 0.0 ap 0.47
Zmax rec p 1.25 ( ; ) under criterion 2vp 0.0 ap 0.33
and 3, respectively. On chromosome X, markers
DXS7132 and DXS6789, located ∼10 cM apart, re-
sulted in Zmax dom p 1.48 ( ; ) and Zmaxvp 0.14 ap 1.0
dom p 1.20 ( ; ) under criterion 2 andvp 0.0 ap 0.64
Zmaxdomp 1.89 ( ; ) and Zmaxdomp 1.82vp 0.12 ap 1.0
(at ; ) under criterion 3, respectively.vp 0.0 ap 0.68
Promising pairwise LOD scores on chromosome X
prompted us to perform nonparametric multipoint anal-
ysis under criterion 3, using the GENEHUNTER pro-
gram. The maximum MLS of 2.75 ( ) wasPp .002733
obtained close to marker DXS7132 in this set of families
(fig. 3b).
On chromosome 7, five of six markers covering a 30-
cM region from D7S1824 to D7S550 showed a Zmax dom
11.0 under criterion 3. Zmax dom p 3.04 ( ;vp 0.0 ap
) was obtained under criterion 3 at D7S2462, with1.0
Zmax dom p 3.04 ( ; ), located ∼58 cMvp 0.0 ap 1.0
telomerically from the recently published autism locus
(IMGSAC 2001a). Parametric multipoint analysis was
performed for each of the diagnostic classes with SIM-
WALK 2.81. Under criterion 3, a maximumMLS of 3.66
under the dominant model of inheritance was observed
at D7S2462 with a value of 1.0 (fig. 3a). The corre-
sponding LOD scores under criterion 2 were systemat-
ically lower (table 2).
Fine-Mapping Results (Stage II)
Nine chromosomal regions showing two-point LOD
scores 11.0 in the initial scan were fine mapped with an
additional 60 markers. At this stage, 19 additional fam-
ilies with 40 individuals affected with autism, AS, or
dysphasia were included in the analyses (table 1).
Chromosomes 7, 9, 12, 14, 17, 18, and 21.—On
chromosome 7, analysis of the AUTS1 locus with five
markers (D7S480, D7S1804, D7S2437, D7S684, and
D7S1824) did not give evidence for linkage using di-
agnostic criterion 1 and 2 (pairwise LOD scores !1).
Under criterion 3, a Zmax dom p 1.05 ( ; )vp 0 ap 0.44
was obtained at D7S1824.
Fine mapping on chromosomes 9, 12, 18, and 21 (ta-
ble 3) did not increase the evidence for linkage when
compared to the initial genome-scan results (stage I). On
chromosome 14, a Zmaxdom of 1.60 ( ; ) wasvp 0 ap 1.0
detected at D14S297 using diagnostic criterion 1 (table
3). The evidence for linkage was less significant under
criterion 2 and 3 in stage II when compared with stage
I results. On chromosome 17, two additional flanking
markers, D17S1806 and D17S1830, located ∼2 cM
apart were analyzed (table 3). Under criterion 1, all three
markers provided suggestive evidence for linkage with
Zmax rec of 1.50 ( ; ) at D17S1806, Zmaxvp 0.1 ap 0.66
rec of 1.82 ( ; ) at D17S784 and Zmax recvp 0.1 ap 0.7
of 1.78 ( ; ). The best Zmax dom of 2.16vp 0 ap 0.37
( ; ) were obtained for D17S784 undervp 0 ap 0.45
criterion 3.
Chromosome 3.—On chromosome 3p, the highest
LOD scores were obtained under criterion 3 (38 families;
87 affected individuals) at D3S3038 (Zmax rec p 1.53;
; ) and D3S3659 (Zmax rec p 1.72;vp 0.06 ap 0.36
; ) which are located ∼2.6 cM apart.vp 0.0 ap 0.38
Inclusion of additional families and adoption of a dom-
inant model of inheritance resulted in lower LOD scores
in stage II (table 3) when compared to the results in
stage I (table 2).
For chromosome 3q, a total of 29 markers in an ∼85
cM interval were genotyped (average intermarker dis-
tance 2.7 cM). The highest two-point LOD score ofZmax
dom p 4.31 ( ; ) and ASP LOD score ofvp 0.0 ap 1.0
4.21 (identical-by-descent [IBD] sharing 82%) were ob-
served at D3S3037 under criterion 2 (table 3). In the 5-
cM interval between D3S2421 and D3S3730, six mark-
ers gave significant evidence for linkage under locus
homogeneity [Zmax dom ( ) 1 3.0)] (table 3). Undervp 0
criterion 1, the highest ASP LOD score of 3.16 (IBD
sharing 84%) was generated at D3S3037 (table 3). Un-
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Figure 2 The two-point LOD scores under homogeneity obtained from the whole genomewide screen under different diagnostic categories:
diagnostic criterion 1, families with infantile autism (A);. diagnostic criterion 2, families with infantile autism and AS (B);. and diagnostic
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Table 3
Maximum Pairwise LOD Scores (Zmax dom) and Affected Sib-Pair






Zmax dom ASP Zmax dom ASP Zmax dom ASP
D1S1675 149.20 1.98 1.69 2.63 1.67 1.07 .95
D1S498 155.89 2.32 1.40 .59 .51 .10 .09
D1S2715 159.32 1.76 .84 .27 .10 .15 .17
D1S2125 163.34 1.58 1.32 .88 .25 .20 .00
D1S1653 164.09 1.52 .93 1.03 .47 .19 .00
D1S2771 168.52 1.20 .82 1.45 .99 .10 .10
D3S3038 44.81 .46 .11 .38 .40 .76 .96
D3S3659 47.44 .35 .18 .86 .38 1.26 .42
D3S3053 181.87 1.69 2.01 2.68 2.73 2.06 1.88
D3S1556 183.47 1.55 1.18 2.56 1.66 1.76 .89
D3S2421 186.68 2.30 1.27 3.51 2.80 1.20 1.21
D3S2427 188.29 2.40 2.10 3.05 2.48 .81 .80
D3S3676 188.29 1.75 1.56 2.18 1.85 .79 .70
D3S3041 188.29 2.74 2.15 3.55 2.88 1.55 1.41
D3S3715 190.43 2.22 .68 2.37 1.65 .55 .49
D3S3037 190.43 2.88 3.16 4.31 4.21 2.65 2.28
D3S3699 191.79 2.27 2.08 3.04 2.49 .47 .46
D3S3730 191.79 1.96 1.64 3.21 2.72 1.49 1.24
D3S3583 195.60 1.51 .84 .97 .87 .57 .57
D9S158 161.71 .63 .65 .48 .16 .19 .01
D12S2078 149.60 1.02 .71 1.19 .67 .33 .22
D14S297 31.75 1.60 1.38 .22 .22 .03 .04
D17S1806 114.41 1.25 1.16 .86 .61 1.24 .94
D17S784 116.86 1.67 1.23 1.92 .22 2.16 .63
D17S1830 116.86 1.44 .98 1.11 .20 1.12 .43
D18S59 .00 .55 .72 .41 .44 .04 .00
D21S1440 36.10 .41 .53 .27 .23 .16 .21
NOTE.—Markers showing LOD scores 13.0 are set in boldface
italics.
Figure 4 A common ancestor originating from central Finland
was detected for core families 1 and 3. The shared chromosomal seg-
ment on 3q25-27 was observed in four patients with autism. Blackened
symbols denote infantile autism, and symbols with vertical lines denote
developmental dysphasia.
der criterion 2, a Zmax rec of 4.21 was observed at
D3S3037 ( ; ). Parametric MLS analysisvp 0.1 ap 1.0
on the chromosome 3q region that allows for locus het-
erogeneity resulted in a maximum MLS of 4.81 with an
a value of 1.0 under criterion 2 and using the dominant
mode of inheritance (fig. 3c). In multipoint analyses, the
maximum MLS values of 3.01 ( ) and 2.08ap 1.0
( ) were observed at D3S3037 under criteria 1ap 0.65
and 3, respectively (fig. 3c).
Chromosome 1.—A total of 15 additional markers
covering ∼27 cM were genotyped, the average inter-
marker distances being 1.4 cM. Under the dominant
model of inheritance the highest Zmax dom of 2.63 was
generated under criterion 2 for D1S1675 (table 3). Under
the recessive model, the best pairwise LOD scores were
obtained under criterion 1: at D1S1675 (Zmax recp 1.98;
; ) 2.7 cM D1S534 (Zmax rec p 1.11;vp 0.12 ap 1.0
; ) 4 cM D1S498 (Zmax rec p 1.64;vp 0.22 ap 1.0
; ) – 7.5 cM – D1S2125 (Zmax rec pvp 0.16 ap 1.0
1.73; ; ) – 0.8 cM D1S1653 (Zmax recvp 0.06 ap 0.98
p 1.14; ; ) – 6.8 cM – APOA2 (Zmaxvp 0.18 ap 1.0
rec p 1.01; ; ). ASP analysis resulted invp 0.2 ap 1.0
a significant IBD sharing ratios for alleles of the markers
D1S1675 (80%) and D1S2125 (85%) under criterion 1.
Parametric multipoint analysis was performed under the
dominant mode of inheritance in all diagnostic criteria,
resulting in a maximum MLS of 2.63 at D1S1653 (fig.
3d) under criterion 1.
Haplotype analysis for the linked chromosome 3 re-
gion.—Given that common ancestors from Central Fin-
land were identified in our genealogical search for the
families 1 and 3, included in the genome scan, we mon-
itored for shared chromosomal segments on 3q. Inter-
estingly, all three patients with autism in family 1 shared
identical haplotypes over the 20-cM chromosomal re-
gion between D3S3053 and D3S2436, comprising a to-
tal of 12 markers. In this family, the same maternal and
paternal alleles were transmitted to all affected sibs (fig.
4). In family 3, the sharing of identical haplotype was
observed in the autistic and healthy siblings, but not in
the male patient with dysphasia being separated by 15
generations from the family 1 affected siblings (fig. 4).
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Figure 5 The observed chromosomal segment of ∼4 cM on 3q in 34 core families. Five markers were localized on the contig map of
NCBI. The families are divided into two groups, according to the birthplaces of the grandparents.
We calculated the probability for two relatives, as dis-
tantly related as an offspring in nuclear family 1 and an
offspring in nuclear family 3, to share one allele IBD at
any randomly selected location. The probability of shar-
ing one allele IBD is only 0.000122, making by-chance
effect a highly unlikely possibility.
To further address the issue of a restricted pool of
ancestral alleles for autism-associated DNA region
among affected individuals in this study, we monitored
for marker haplotypes across the 4 cM chromosomal
region on 3q25-27 covered by six markers. The draft
sequence available at the National Council for Biotech-
nology Information (NCBI) Web site was used to order
the markers (fig. 5). Haplotypes were constructed using
the GENEHUNTER program and were monitored in 17
families fulfilling diagnostic criterion 1 (36 affected in-
dividuals), 25 families fulfilling criterion 2 (53 affected
individuals), and in 35 families fulfilling criterion 3 (75
affected individuals), as well as in 18 sib-pair families
originating from Central Finland (41 affected individ-
uals). No single shared haplotype could be identified
among all families (fig. 5). However, chromosome 3 hap-
lotypes shared by at least two affected sibs were detected
in 34 of 35 core families. Allele 11 of D3S3037 was
observed in 65% of affected siblings in families origi-
nating from the Central Finland, compared to 24% of
affected siblings in families originating outside Central
Finland. In the control chromosomes of the whole study
material (nontransmitted alleles of the parents) the fre-
quency of this allele was 19%.
To test whether there are fewer founder alleles among
affected individuals than among control individuals, we
used the Genepop 3.3 program to evaluate the LD across
the key markers in 3q. In alleles transmitted to the in-
dividuals affected under criterion 2, some evidence for
LD was observed between D3S3715 and D3S3037, lo-
cated at the same contig ∼30 kb apart (NT_005503.6)
( ). In individuals affected under diagnosticPp .0108
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Table 4





Criterion 1 Criterion 2 Criterion 3
Central Finland
(Criterion 2)
HRR-LRT TDT GC HRR-LRT TDT GC HRR-LRT TDT GC HRR-LRT TDT GC
Chromosome 3:
D3S2427 188.29 .5000 .0567 .5649 .5000 .0717 .3539 .5000 .1760 .5179 .5000 .1582 .3562
D3S3676 188.29 .5000 .3130 .0853 .5000 .2550 .0321 .5000 .1330 .0660 .5000 .3606 .1410
D3S3041 188.29 .0387 .8050 .5676 .0705 .5580 .3202 .5000 .2910 .1259 .5000 .3532 .3079
D3S3715 190.43 .5000 .4080 .1956 .0828 .3140 .2733 .5000 .7920 .6542 .4971 .2325 .3648
D3S3037 190.43 .5000 .1050 .1330 .5000 .2070 .2308 .5000 .4310 .4176 .5000 .0077 .0063
D3S3699 191.79 .1252 .0127 .0524 .5000 .5370 .4484 .2347 .6530 .6709 .5000 .2180 .0801
D3S3730 191.79 .5000 .1380 .2834 .3585 .0488 .1082 .0952 .0807 .0996 .5000 .1900 .2064
D3S3583 195.60 .5000 .6690 .6733 .5000 .4850 .4803 .5000 .4680 .3546 .5000 .2397 .5144
D3S2436 203.28 .5000 .8480 .8816 .5000 .2380 .4710 .5000 .1350 .2204 .1917 .3716 .7458
Chromosome 1:
D1S1653 164.09 .4957 .0069 .0231 .5000 .0327 .13637 .5000 .1850 .38575 .5000 .3710 .2764
D1S2771 168.52 .0020 .0004 .0028 .0075 .0006 .13080 .1125 .0232 .14521 .0418 .0051 .0091
NOTE.—GC p Gamete competition.
criterion 3, evidence for LD emerged from markers
D3S3715 and D3S3699, separated by 1.4 cM (Pp
). In alleles of affected individuals in families from.0960
Central Finland, some evidence for LD could be detected
across a 2.14-cM region between loci D3S2427 and
D3S3715 ( ). No significant LD could be de-Pp .0562
tected across the markers in alleles not transmitted to
affected individuals ( ). These data would im-Pp .2484
ply for a restricted pool of ancestral alleles for autism-
associated DNA region among patients.
Association Analyses
Association analyses were performed in all diagnostic
categories, for the whole study sample and separately,
using 34 patients affected under diagnostic criterion 2
who originated from Central Finland. Because of the
relatively small sample size, the asymptotic P values
listed for the gamete competition should be considered
approximations of the actual significance. The markers
for association studies were selected on the basis of pos-
itive linkage findings.
On chromosome 3q25-27, a statistically significant
TDT result was observed under criterion 1 (Pp
) (table 4a). In this patient group, the test for hap-.0127
lotype relative risk by likelihood ratio test (HRR-LRT)
showed evidence for association with D3S3041 (P values
of .0387) (table 4). For marker D3S3730, evidence for
association was detected in TDT analysis under criterion
2 ( ). The most significant evidence for asso-Pp .0488
ciation was generated under criterion 2 in families orig-
inating from Central Finland with in TDTPp .0077
and in gamete-competition analysis. WhenPp .0063
monitoring the allele composition between the trans-
mitted and nontransmitted alleles using Genepop 3.3
analysis, differences in were pronounced in the different
groups of families analyzed. At D3S3699, P values of
.00002 (diagnostic criterion 1), .00147 (diagnostic cri-
terion 2), and .00585 (diagnostic criterion 3) were gen-
erated. In families from Central Finland that met cri-
terion 2, P values of .00013 and .02 were observed at
D3S3037 and D3S3699.
In families from Central Finland, an allelic association
was observed for two markers. For marker D3S3037,
allele 11 was observed in 52% of the disease chromo-
somes and in 14% of the control chromosomes in fam-
ilies ( ; ). For marker D3S3699,Pp .0203 lp 0.421
58% of autism chromosomes shared allele 7; this allele
was present in 16% of the control chromosomes in in-
dividuals affected under criterion 1 ( ;Pp .0120 lp
).0.479
Also, for markers on chromosome 1, association anal-
yses showed evidence for allelic association in all diag-
nostic classes for marker D1S2771, which was located
∼4 cM telomerically from D1S1653 (table 4). In TDT
analysis, the best P value, .0004, was detected formarker
D1S2771 under criterion 1. Evidence of association in
TDT was also observed for D1S1653 in individuals af-
fected under criteria 1 and 2 (table 4).
Discussion
The most promising locus to emerge from our genome-
wide scan was on chromosome 3q, representing a new
locus for the autism-spectrum phenotype. The markers
in this region showed linkage and some evidence for
association, as well as increased intermarker LD, imply-
ing shared ancestral alleles among affected individuals
in the vicinity of markers D3S3037 and D3S3699.
Markers on 1q also provided some evidence for linkage
in our study sample of 38 families.
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While we established the specific clinical diagnoses
for the affected individuals in our study sample, we
found many relatives of autistic individuals to present
the broad phenotypic spectrum of autism. The family
members with AS and developmental dysphasia were
diagnostically classified, and this information was used
in the linkage analyses to define three diagnostic cate-
gories. To be able to fully compare our results with the
previously published genomewide screens, infantile au-
tism was selected as a target diagnostic group. Conse-
quently, the loci for fine mapping were selected on the
basis of the data from a primary genome scan performed
in 12 families and using infantile autism (diagnostic
criterion 1) as an affection status.
Our results on chromosome 1p, although only sug-
gestive, can be interpreted as a replication of the sug-
gestive linkage reported by Risch et al. (1999) in 139
sibships with mixed American origin. They reported a
maximum MLS of 2.15 at D1S1675 in the largest ge-
nomewide screen for autism published so far (Risch et
al. 1999). We obtained the Zmax dom of 1.98 with the
same marker, D1S1675, in 19 families meeting criterion
1 and theZmaxdom of 2.63 in 28 families meeting criterion
2. Some evidence for linkage also emerged for the long
arm of chromosome 1. For families meeting criterion
1, we found a maximum MLS of 2.63 near D1S1653,
located ∼13 cM distally from marker D1S1675. No
linkage reports in autism have been reported in this
chromosomal region, but, interestingly, an MLS of 6.50
close to marker D1S1653 was recently reported in a
study of schizophrenia (Brzustowicz et al. 2000). It is
of interest that earlier family studies have shown in-
creased rates of schizoid personality traits in families
with autism. These neuropsychiatric disorders could
share a susceptibility gene or genes in this particular
chromosomal region (Piven et al. 1994, 1997a, 1997b;
Murphy et al. 2000).
Chromosomes 7q and X provided some linkage ev-
idence in families meeting criterion 3. The putative au-
tism-predisposing region on chromosome 7q colocalizes
with the locus for specific language development
(SPCH1), for which the gene was recently identified
(Fisher et al. 1998; Ashley-Koch et al. 1999; Lai et al.
2000; Lai et al. 2001; IMGSAC 2001a). In our families,
fine mapping of the previously reported AUTS1 locus
did not show any evidence for linkage under diagnostic
criterion 1 or 2 on this region. The best result under
criterion 3, a Zmax dom of 1.05 (v p 0, a p 0.44), was
detected at D7S1824. Interestingly, a Zmax dom of 3.04
was obtained at D7S2462 locating ∼58 cM telomeri-
cally from the AUTS1 locus (IMGSAC 2001a). This
particular marker also showed evidence for association
in our study sample in TDT and gamete competition
test. Liu et al. (2001) reported a maximumMLS of 2.13
with 110 sib-pair families with a broad phenotype (au-
tism, AS, or PDD) at D7S483 that resides ∼4.6 cM
proximal from our best marker D7S2462. Taken to-
gether, our results provide further support for a locus
predisposing to autism-spectrum disorders, locating
markedly telomerically than the previously published
AUTS1 locus (IMGSAC 2001a).
For the X chromosome, a Zmax dom of 1.89 was ob-
tained at DXS7132 in families meeting criterion 3, and
the nonparametric MLS analysis resulted in a maximum
MLS of 2.75 close to this same marker. One earlier
genome scan has produced positive signals on chro-
mosome X (Liu et al. 2001). The MLS of 2.56 was
obtained at DXS1047, located ∼30 cM distally from
our peak of linkage, using 110 multiplex families and
the broad phenotype classification. The increased male-
to-female ratio in PDD is well established (Skuse 2000).
Further studies based on putative linkage findings on
chromosome X could provide a molecular basis for this
difference.
Loci on chromosome 14q and 17q provided only sug-
gestive evidence for linkage. These findings could still
be interesting, since some positive LOD scores have pre-
viously been reported for chromosome 14 in British
families (IMGSAC 1998) and for chromosome 17 in
American families (Risch et al. 1999). For chromosome
17, the locus was reported in the mixed American sam-
ple set (Risch et al. 1999), with markers locating at a
significant distance, 104 cM, proximal to our region. A
Zmax of 2.19 at D17S784 was previously reported for
familial schizophrenia (Brzustowicz et al. 2000). Thus,
as in the case of chromosome 1q, these findings raise
the possibility of shared susceptibility gene(s) underly-
ing infantile autism and schizophrenia.
Recently, association strategies for mapping complex
human disorders have been strongly advocated, espe-
cially in isolated populations (Shifman and Darvasi
2001). The families in our study originate from the iso-
lated population of Finland, with a limited number of
founders and multiple population bottlenecks, espe-
cially in regional isolates with little immigration and
rapid expansion (Peltonen et al. 1999). In the Finnish
population, the mapping for predisposing loci has been
accomplished for many common diseases, including co-
lon cancer (Peltomaki et al. 1993), diabetes (Mahtani
et al. 1996), multiple sclerosis (Kuokkanen et al. 1997),
familial combined hyperlipidemia (Pajukanta et al.
1998), schizophrenia (Ekelund et al. 2000), and asthma
(Laitinen et al. 2001). On the basis of the initial linkage
finding on chromosome 3q, this particular region was
analyzed for association in families originating from a
subisolate of central Finland. The observed linkage was
supported by the association observed at D3S3037 in
families from central Finland. Further, whenmonitoring
for the intermarker LD in disease alleles of individuals
affected under criterion 2, we found increased LD in-
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tervals with markers on the same region, suggesting a
restricted number of ancestor chromosomes in this re-
gional subisolate.
Careful definition of the phenotype is one of themajor
challenges in mapping complex disease traits—partic-
ularly behavioral neuropsychiatric phenotypes. Splitting
the phenotype into endophenotypes or using a broad
clinical phenotype has resulted in significant evidence
for predisposing loci in linkage analyses of some phe-
notypes (Brzustowicz et al. 2000; Stober et al. 2000).
Here, the best results were obtained with the broad
autism phenotype (infantile autism and AS), partly be-
cause the broad classification increased the number of
affected family members from 54 to 87, increasing the
information content in the affected-only analyses. The
results indicate a novel gene locus (AUTS2) for autism-
spectrum disorders on chromosome 3q25-27. The sig-
nificance of this finding is supported by the suggestive
association and skewing of the marker alleles in disease
chromosomes from the genetically isolated Finnish sub-
population from Central Finland, which may facilitate
the positional cloning of a susceptibility gene. Repli-
cation studies are warranted to confirm whether this
region contains a predisposing gene shared by other
populations or whether it is a rare locus unique to the
Finns.
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